Intellectual Property UK

  • March 31, 2025

    Novartis, Genentech Lose Asthma Drug Patent In Netherlands

    Celltrion Inc. has persuaded a Dutch court to revoke Novartis and Genentech's patent in the Netherlands for asthma drug omalizumab, straying from a London judge's recent decision to uphold the U.K. part of the patent.

  • March 31, 2025

    Boult Wade Atty Named Chief Of IP Group's UK Arm

    A European intellectual property union has named a Boult Wade Tennant LLP partner as the new president of its British group.

  • March 31, 2025

    Adidas Refused Broader Protection For Sports Shoe Patent

    European patent officials have rejected a bid by Adidas AG for a broader version of a patent for one of its sports shoe designs but disagreed with a Swiss competitor that the patent should be scrapped entirely.

  • March 31, 2025

    Session Musicians Need Streaming Revenue Fix, Union Says

    The Musicians' Union has pushed the government to give session musicians a share of streaming royalties, noting that a recent increase in upfront studio fees wasn't enough to balance the scales given the streaming industry's gains.

  • March 31, 2025

    LVMH Units Win Glenmorangie, Belvedere Counterfeits Claim

    Two LVMH-owned companies behind Scotch whisky brand Glenmorangie and Polish vodka Belvedere have convinced a court in the Netherlands that a Chinese company infringed their trademarks by importing and storing thousands of counterfeit bottles.

  • March 31, 2025

    Nokia, Amazon End Long-Running Patent Feud With License

    Nokia said Monday that it has inked a patent agreement with Amazon to cover its video technology, marking the end of litigation between the two companies across several continents.

  • March 28, 2025

    Patent Court Likely To Lure Patent Holders With UK IP In Play

    The Unified Patent Court has now doubled down on its authority to hear claims involving U.K. patents, a move that is likely to make the court an even more desirable forum for global infringement actions.

  • March 28, 2025

    VistaJet Escapes VC Fund's Claim Over Investment Deal

    A private jet company owner escaped allegations from a Guernsey venture capital fund that he secretly set up companies to leverage the resources of a business it had invested in, when a London court ruled Friday that the claim came too late.

  • March 28, 2025

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen sparkling winemaker Nyetimber hit a rival distillery with an intellectual property claim, Newcastle United's former owner Mike Ashley target the club's ex-vice president for damages tied to a fraudulent investment, and a real estate agency file a legal claim against law firm Winston & Strawn LLP. Here, Law360 looks at these and other new claims in the U.K.

  • March 28, 2025

    CureVac RNA Vax Patent Survives BioNTech's EU Challenge

    CureVac SE has fended off a challenge from BioNTech SE of its mRNA therapy patent at a European patent authority, paving the way for CureVac to forge ahead with litigation in the companies' home country of Germany accusing BioNTech of infringing its invention.

  • March 28, 2025

    Pharma Co. Sues Ex-VP For Trade Theft To Benefit Rival

    A pharma company has sued its former senior vice president, accusing him of secretly downloading confidential information in order to share it with a rival weeks before he resigned. 

  • March 28, 2025

    MSD Loses Appeal Over Ruling It Broke 'Merck' Branding Ban

    A London appeals court upheld on Friday a ruling that U.S.-based Merck Sharp & Dohme LLC breached a court order blocking its use of the name "Merck" in a move to safeguard German rival Merck KGaA's trademark rights.

  • March 28, 2025

    AstraZeneca Can't Stop Generic Diabetes Drug Launch

    AstraZeneca has lost an attempt to prevent pharmaceutical company Glenmark from launching a generic version of its $1 billion diabetes drug Forxiga, as a London court refused on Friday to stop the generic maker before a decision on whether AstraZeneca's patent is valid.

  • March 27, 2025

    AstraZeneca Fights Generic Diabetes Drug Launch

    AstraZeneca on Thursday asked a London court to block pharmaceutical company Glenmark from launching a generic version of the drug giant's $1 billion Type 2 diabetes treatment Forxiga, ahead of a decision on whether AstraZeneca's patent is valid.

  • March 27, 2025

    Warner Bros 'Multiversus' UK TM Gets Green Light

    Warner Bros. can register a trademark for its online multiplayer game Multiversus, after British officials ruled that gamers would think it was entirely disconnected from a rival firm's "Versus" brand.

  • March 27, 2025

    Parties Can Dodge Costs By Surrendering Patents, UPC Says

    Parties facing challenges to their patents can swerve liability for their opponent's costs by giving up their intellectual property protections at the outset of the dispute, an appeals panel at the Unified Patent Court has ruled.

  • March 27, 2025

    Beverage Biz Can't Corner The Market For 'Norwich City' TM

    U.K. trademark officials have chucked a drinks maker's bid for a "Norwich City" trademark for alcoholic drinks, rejecting the company's argument that it should be allowed because the city's football club already owns a trademark for "Norwich City FC."

  • March 27, 2025

    Top EU Court Urged To Uphold €60M Teva Pay-For-Delay Fine

    An adviser to the European Union's top court said Thursday that it should uphold €60.5 million ($70.7 million) in fines against Teva and its subsidiary Cephalon for an alleged conspiracy to keep a generic version of Provigil off the shelves.

  • March 27, 2025

    Unitary Patent Uptake 'Surpassing Expectations,' EPO Says

    The European Patent Office has said it received more than 28,000 requests for unitary protection in its second year as more than a quarter of applicants sought to protect their inventions under the new framework.

  • March 26, 2025

    Claims Firm Beats Whistleblower's Fraud Case

    A claims manager didn't blow the whistle on forged signatures at an insurance claims handler because he had waited until his resignation day to alert senior management, an employment tribunal has ruled.

  • March 26, 2025

    Software Developer Loses 'Baidu' TM On Appeal

    A Dutch provider of software for TV channels has lost its rights to use "Baidu" as a trademark, after a European court found that it hadn't used the name to market goods and services it had applied for.

  • March 26, 2025

    Bacardi Halts Counterfeit Grey Goose Bottles At Dutch Court

    Bacardi has convinced a Dutch court to bar a Hong Kong drinks trader from selling counterfeit Grey Goose vodka in the Netherlands, after the court found the company had infringed Bacardi's protected branding.

  • March 26, 2025

    Cannabis Event Biz Loses Bid For 'Cannafair' TM

    A European court threw out a challenge by cannabis trade fair company Cannafair on Wednesday over the decision by European trademark officials to refuse a trademark for the name of its event, ruling that its name was a literal description of the event.

  • March 26, 2025

    Lotus Biscoff Loses EU Appeal To Register Color TM

    Lotus Bakeries NV has lost another bid to protect the red and white coloring of its biscuit packaging after failing to convince European officials that shoppers would immediately recognize its brand.

  • March 26, 2025

    EU Court Upholds Polish Biz's Rights To Public Toilet Design

    A European Union court has rejected a Polish company's latest bid to quash a rival's protections for a public toilet design, ruling Wednesday that the design was new and consequently valid.

Expert Analysis

  • Aldi Design Infringement Case Highlights Assessment Issues

    Author Photo

    The forthcoming English Court of Appeal decision in Marks and Spencer v. Aldi, regarding the alleged infringement of design rights, could provide practitioners with new guidance, particularly in relation to the relevant date for assessment of infringement and the weight that should be attributed to certain design elements in making this assessment, say Rory Graham and Georgia Davis at RPC.

  • Generative AI Raises IP, Data Protection And Contracts Issues

    Author Photo

    As the EU's recent agreement on the Artificial Intelligence Act has fueled businesses' interest in adopting generative AI tools, it is crucial to understand how these tools utilize material to generate output and what questions to ask in relation to intellectual property, data privacy and contracts, say lawyers at Deloitte Legal.

  • Vodafone Decision Highlights Wide Scope Of UK's FDI Rules

    Author Photo

    The U.K. government’s recently imposed conditions required for its approval of Vodafone and Etisalat’s strategic relationship agreement under its National Security and Investment Act jurisdiction, illustrating the significance of the act as an important factor for transactions with a U.K. link, says Matthew Hall at McGuireWoods.

  • What The EU AI Act Could Mean For Patent Law

    Author Photo

    As the EU Artificial Intelligence Act has now been endorsed by all member states, companies and patent owners with interests in the bloc may want to prepare for when the act enters into force, including by considering potential subject matter exclusions, says Terence Broderick at Murgitroyd.

  • Considering A Practical FRAND Rate Assessment Procedure

    Author Photo

    As the debate over a fair, reasonable and nondiscriminatory rate continues inside and outside courtrooms, a practical method may assess whether the proposed FRAND rate deviates significantly from what is reasonable, and ensure an optimal mix of assets for managers of standard-essential patent portfolios, says consultant Gordon Huang.

  • How AI Inventorship Is Evolving In The UK, EU And US

    Author Photo

    While the U.K. Supreme Court's recent decision in Thaler v. Comptroller-General is the latest in a series of decisions by U.K., U.S. and EU authorities that artificial intelligence systems cannot be named as inventors in patents, the guidance from these jurisdictions suggests that patents may be granted to human inventors that use AI as a sophisticated tool, say lawyers at Mayer Brown.

  • Cos. Should Plan Now For Extensive EU Data Act Obligations

    Author Photo

    The recently enacted EU Data Act imposes wide-ranging requirements across industries and enterprises of all sizes, and with less than 20 months until the provisions begin to apply, businesses planning compliance will need to incorporate significant product changes and revision of contract terms, say Nick Banasevic, Robert Spano and Ciara O'Gara at Gibson Dunn. 

  • UK Ruling Revitalizes Discussions On Harmonizing AI And IP

    Author Photo

    The U.K. Supreme Court's decision in Thaler v. Comptroller-General last month has reinvigorated ongoing discussions about how the developments in artificial intelligence fit within the existing intellectual property legislative landscape, illustrating that effective regulation will be critical as the value and influence of this sector grows, say Nick White and Olivia Gray at Charles Russell.

  • AI Inventorship Patent Options After UK Supreme Court Ruling

    Author Photo

    The U.K. Supreme Court's recent ruling in Thaler v. Comptroller-General of Patents, Designs and Trade Marks that an AI system cannot be an inventor raises questions about alternative approaches to patent protection for AI-generated inventions and how the decision might affect infringement and validity disputes around such patents, says David Knight at Brown Rudnick.

  • Acquisition Of AI Tech Poses Challenges For Media Industry

    Author Photo

    The artificial intelligence regulatory landscape is changing quickly, and media and entertainment companies planning to acquire AI technology through a merger, acquisition or licensing deal should be mindful of potential new compliance requirements and AI-specific insurance products, say lawyers at Covington.

  • Cos. Should Weave Metaverse Considerations Into IP Strategy

    Author Photo

    In light of the increasing importance of intellectual property protection in digital contexts, including a growing number of court rulings and recent updates to the classification of digital assets, companies should include the metaverse as part of their trademark strategy to prevent potential infringements, says Gabriele Engels at D Young & Co.

  • Mitigating Compliance And Litigation Risks Of Evolving Tech

    Author Photo

    Amid artificial intelligence and other technological advances, companies must prepare for the associated risks, including a growing suite of privacy regulations, enterprising class action theories and consumer protection challenges, and proliferating disclosure obligations, say attorneys at Eversheds Sutherland.

  • Major EU AI Banking Ruling Will Reverberate Across Sectors

    Author Photo

    Following the European Court of Justice's recent OQ v. Land Hessen decision that banks' use of AI-driven credit scores to make consumer decisions did not comply with the General Data Protection Regulation, regulators indicated that the ruling would apply broadly, leaving numerous industries that employ AI-powered decisions open to scrutiny, say lawyers at Alston & Bird.

  • English Could Be The Future Language Of The UPC

    Author Photo

    While most Unified Patent Court proceedings are currently held in German, the recent decisions in Plant-e v. Arkyne and Amgen v. Sanofi potentially signal that English will be the preferred language, particularly in cases involving small and medium enterprises, say lawyers at Freshfields.

  • Arbitration Remains Attractive For Digital Disputes In 2024

    Author Photo

    Recent regulatory and digital forum developments highlight that, in 2024, arbitration will continue to adapt to new technologies, such as artificial intelligence and cryptocurrency, and remain an attractive forum for resolving digital disputes due to its flexibility, confidentiality and comparative ease to enforce cross-border awards, says Peter Smith at Charles Russell.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!